Moody National Bank Trust Division’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.23M | Sell |
2,484
-33
| -1% | -$14.6K | 0.1% | 200 |
|
|
2026
Q1 | $1.12M | Buy |
2,517
+41
| +2% | +$19.1K | 0.11% | 187 |
|
|
2025
Q4 | $1.12M | Sell |
2,476
-1,173
| -32% | -$506K | 0.11% | 195 |
|
|
2025
Q3 | $1.43M | Buy |
3,649
+208
| +6% | +$86.9K | 0.12% | 179 |
|
|
2025
Q2 | $1.53M | Sell |
3,441
-92
| -3% | -$42.4K | 0.14% | 159 |
|
|
2025
Q1 | $1.71M | Buy |
3,533
+48
| +1% | +$22.4K | 0.18% | 127 |
|
|
2024
Q4 | $1.4M | Sell |
3,485
-176
| -5% | -$81.6K | 0.15% | 164 |
|
|
2024
Q3 | $1.7M | Sell |
3,661
-27
| -0.7% | -$13K | 0.18% | 130 |
|
|
2024
Q2 | $1.73M | Buy |
3,688
+111
| +3% | +$48.2K | 0.13% | 103 |
|
|
2024
Q1 | $1.5M | Buy |
3,577
+11
| +0.3% | +$4.65K | 0.12% | 129 |
|
|
2023
Q4 | $1.45M | Sell |
3,566
-2,952
| -45% | -$1.09M | 0.11% | 135 |
|
|
2023
Q3 | $2.27M | Buy |
6,518
+809
| +14% | +$283K | 0.15% | 111 |
|
|
2023
Q2 | $2.01M | Buy |
5,709
+60
| +1% | +$20.2K | 0.14% | 112 |
|
|
2023
Q1 | $1.78M | Sell |
5,649
-8
| -0.1% | -$2.4K | 0.15% | 117 |
|
|
2022
Q4 | $1.63M | Buy |
5,657
+9
| +0.2% | +$2.74K | 0.14% | 122 |
|
|
2022
Q3 | $1.64M | Hold |
5,648
| – | – | 0.17% | 116 |
|
|
2022
Q2 | $1.59M | Sell |
5,648
-654
| -10% | -$175K | 0.17% | 103 |
|
|
2022
Q1 | $1.64M | Sell |
6,302
-794
| -11% | -$188K | 0.05% | 136 |
|
|
2021
Q4 | $1.56M | Sell |
7,096
-22,379
| -76% | -$4.35M | 0.05% | 171 |
|
|
2021
Q3 | $5.35M | Sell |
29,475
-19
| -0.1% | -$3.71K | 0.08% | 162 |
|
|
2021
Q2 | $5.95M | Sell |
29,494
-374
| -1% | -$78.2K | 0.12% | 150 |
|
|
2021
Q1 | $6.42M | Buy |
29,868
+102
| +0.3% | +$22.4K | 0.15% | 128 |
|
|
2020
Q4 | $7.04M | Buy |
29,766
+117
| +0.4% | +$26.8K | 0.18% | 110 |
|
|
2020
Q3 | $8.07M | Hold |
29,649
| – | – | 0.25% | 80 |
|
|
2020
Q2 | $8.61M | Buy |
29,649
+95
| +0.3% | +$25.8K | 0.27% | 74 |
|
|
2020
Q1 | $7.03M | Hold |
29,554
| – | – | 0.25% | 73 |
|
|
2019
Q4 | $6.47M | Hold |
29,554
| – | – | 0.17% | 101 |
|
|
2019
Q3 | $5.01M | Buy |
29,554
+85
| +0.3% | +$15K | 0.14% | 115 |
|
|
2019
Q2 | $5.4M | Hold |
29,469
| – | – | 0.15% | 113 |
|
|
2019
Q1 | $5.42M | Buy |
29,469
+15
| +0.1% | +$2.77K | 0.15% | 113 |
|
|
2018
Q4 | $4.88M | Buy |
29,454
+179
| +0.6% | +$31K | 0.14% | 113 |
|
|
2018
Q3 | $5.64M | Buy |
29,275
+26,560
| +978% | +$4.73M | 0.14% | 123 |
|
|
2018
Q2 | $462K | Hold |
2,715
| – | – | 0.02% | 156 |
|
|
2018
Q1 | $442K | Buy |
2,715
+1,407
| +108% | +$230K | 0.02% | 166 |
|
|
2017
Q4 | $417K | Buy |
+1,308
| New | +$194K | 0.02% | 179 |
|
Other funds holding VRTX
Moody National Bank Trust Division's VRTX Position: Q2 2026 in Review
Moody National Bank Trust Division reduced its Vertex Pharmaceuticals (VRTX) stake by 1.3% in Q2 2026, selling an estimated $14.6K and leaving 2,484 shares worth $1.23M. The position accounts for 0.1% of the portfolio, ranked #200.
Moody National Bank Trust Division first reported a position in VRTX in Q4 2017 and has held it in 35 quarters since. The position peaked at $8.61M in Q2 2020. 875 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Moody National Bank Trust Division held 2,484 shares of Vertex Pharmaceuticals worth $1.23M as of Q2 2026.
- Moody National Bank Trust Division sold 33 Vertex Pharmaceuticals shares in Q2 2026, an estimated $14.6K.
- Vertex Pharmaceuticals made up 0.1% of Moody National Bank Trust Division's portfolio in Q2 2026, its #200 holding.
- Moody National Bank Trust Division first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 35 quarters since.
- Moody National Bank Trust Division's Vertex Pharmaceuticals position peaked at $8.61M in Q2 2020.
- 875 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Moody National Bank Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.